Showing results (31-40 of 331) with videos related to
Sort By:
Pageof 34
Personalized Medicine|September 2, 2017
Enabling a genetically informed approach to cancer medicine: evaluation of the impact of comprehensive tumor sequencingElizabeth J Davis, Douglas B JohnsonCurrent Treatment Options in Oncology|November 20, 2019
Management of V600E and V600K BRAF-Mutant MelanomaAlexandra M Haugh, Douglas B JohnsonMelanoma Management|September 8, 2018
Biomarkers in melanoma: where are we now?Douglas B Johnson, Ryan J SullivanInternational Journal of Radiation Oncology, Biology, Physics|July 11, 2023
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical TrialMeridith L Balbach, Alexander D Sherry, Brent N Rexer, et al.BMC Medical Education|April 12, 2024
Developing an educational "hub": impact of a distance-learning curriculum in a multinational cohortMeridith L Balbach, Grantly Neely, Afua Yorke, et al.Journal of Leukocyte Biology|June 4, 2016
Combinatorial approach to cancer immunotherapy: strength in numbersAnna E Vilgelm, Douglas B Johnson, Ann RichmondBMJ Open Respiratory Research|March 5, 2025
Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitisAndrea Davis, Douglas B Johnson, Julie A BastaracheCurrent Treatment Options in Oncology|August 7, 2014
Immune checkpoint inhibitors in NSCLCDouglas B Johnson, Matthew J Rioth, Leora HornTherapeutic Advances in Medical Oncology|March 11, 2015
Nivolumab in melanoma: latest evidence and clinical potentialDouglas B Johnson, Chengwei Peng, Jeffrey A SosmanExpert Opinion on Biological Therapy|March 28, 2015
Trametinib in the treatment of melanomaRamya Thota, Douglas B Johnson, Jeffrey A SosmanPageof 34